Acadia Pharmaceuticals Inc

ALGERT GLOBAL LLC ACAD

Report date

3/31/2026

Quarter

2026 Q1

Filed

8/10/2026

Shares

140,462

Value ($000)

3,127

Weight

0.0%

2022 Q4 - 2026 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	8/10/2026	3,127	0.0%	140,462	3/31/2026
2025 Q4	8/10/2026	16,411	0.3%	614,410	12/31/2025
2025 Q3	8/10/2026	8,538	0.1%	400,109	9/30/2025
2025 Q2	8/10/2026	1,145	0.0%	53,092	6/30/2025
2025 Q1	8/10/2026	5,809	0.1%	349,704	3/31/2025
2024 Q4	8/10/2026	8,916	0.2%	485,904	12/31/2024
2024 Q3	8/10/2026	8,451	0.2%	549,456	9/30/2024
2024 Q2	8/10/2026	8,680	0.3%	534,143	6/30/2024
2024 Q1	8/10/2026	6,552	0.3%	354,344	3/31/2024
2023 Q4	8/10/2026	8,168	0.3%	260,877	12/31/2023
2023 Q3	8/10/2026	2,324	0.1%	111,534	9/30/2023
2023 Q2	8/10/2026	2,662	0.1%	111,154	6/30/2023
2023 Q1	8/10/2026	2,666	0.1%	141,664	3/31/2023
2022 Q4	8/10/2026	2,778	0.2%	174,519	12/31/2022